PALXOTCSemiconductors & Related DevicesFiscal year ends December 31
Palomino Laboratories Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$14.00−0.32 (-2.23%)
Close on Oct 15, 2026
- Market cap
- $305.46M
- P/E (TTM)
- –
- Dividend yield
- –
Palomino Laboratories Inc. revenue by segment
By business segment
| Operating income | Q2 25 | Q1 25 | Q2 24 | Q1 24 | YoY |
|---|---|---|---|---|---|
| Others [Member] | $0 | -$517 | -$58 | – | -100.0% |
| Director Fees [Member] | -$3.00K | -$3.00K | -$3.00K | -$3.00K | 0.0% |
| Legal Fees [Member] | -$9.00K | -$9.00K | -$9.00K | -$9.00K | 0.0% |
| Accounting And Other Professional Services [Member] | -$23.55K | -$41.01K | -$19.73K | -$39.30K | +19.3% |
By product or service
By region
From the segment and revenue-disaggregation notes of Palomino Laboratories's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.